跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION - HSA Drug Approval Details
Approvals
/
HSA
/
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Approved
THERAPEUTIC
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
HP HALDEN PHARMA AS (NORWAY)
🇸🇬 Health Sciences Authority
Approval Date
Sep 4, 1996
Approval ID
11b06e56b13b11f4
Company
HP HALDEN PHARMA AS (NORWAY)
Type
Therapeutic
Approval Details
Approval Id
11b06e56b13b11f4
Drug Name
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Product Name
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Approval Number
SIN08899P
Approval Date
1996-09-04
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
A12CX
Atc Item Name
其它矿物质药物
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
POTASSIUM IODIDE
1.31 mcg/ml
SODIUM FLUORIDE
126 mcg/ml
COPPER CHLORIDE DIHYDRATE
53.7 mcg/ml
MANGANESE CHLORIDE TETRAHYDRATE
3.6 mcg/ml
ZINC CHLORIDE
521 mcg/ml
SODIUM SELENITE ANHYDROUS
4.38 mcg/ml
COPPER CHLORIDE DIHYDRATE
53.7 mcg/ml
MANGANESE CHLORIDE TETRAHYDRATE
3.6 mcg/ml
POTASSIUM IODIDE
1.31 mcg/ml
SODIUM FLUORIDE
126 mcg/ml
SODIUM SELENITE ANHYDROUS
4.38 mcg/ml
ZINC CHLORIDE
521 mcg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 4, 1996
Approval ID
11b06e56b13b11f4
Type
Therapeutic
Back to HSA Approvals
